Park Edge Advisors, LLC

Position in LLY — ELI LILLY & Co

CIK 1965659 Cleveland, OH

Position in LLY

as of Jun 30, 2026 · filed Jul 13, 2026 Compact

Position Value

$1,272,595

+$368,462 QoQ

Shares Held

1,061

+7.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.45%

of 13F equity value

Holder Rank

#2,908

of 4,605 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Park Edge Advisors, LLC holds $9,575,115 across 7 Drug Manufacturers - General names. LLY ranks #3 (13.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	16,584	$4,211,838
2	GILD	Gilead Sciences, Inc.	10,590	$1,337,940
3	LLY	ELI LILLY & Co This page	1,061	$1,272,595
4	ABBV	AbbVie Inc.	3,457	$869,919
5	BMY	Bristol Myers Squibb Co	14,381	$828,633
6	MRK	Merck & Co., Inc.	4,378	$562,573
7	PFE	Pfizer Inc	20,416	$491,617

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,272,595	1,061	+7.9%	Shares	Sole	2026-07-13
2026-03-31	$904,133	983	-19.5%	Shares	Sole	2026-04-20
2025-12-31	$1,312,184	1,221	-30.3%	Shares	Sole	2026-01-16
2025-09-30	$1,336,013	1,751	-9.6%	Shares	Sole	2025-10-09
2025-06-30	$1,509,170	1,936	+10.2%	Shares	Sole	2025-07-07
2025-03-31	$1,451,123	1,757	-17.3%	Shares	Sole	2025-04-10
2024-12-31	$1,639,728	2,124	-6.8%	Shares	Sole	2025-01-21
2024-09-30	$2,018,171	2,278	-7.2%	Shares	Sole	2024-10-24
2024-06-30	$2,223,613	2,456	-4.2%	Shares	Sole	2024-07-26
2024-03-31	$1,993,911	2,563	+70.6%	Shares	Sole	2024-04-19
2023-12-31	$875,545	1,502	+111.8%	Shares	Sole	2024-01-12
2023-09-30	$380,825	709	0.0%	Shares	Sole	2023-10-11
2023-06-30	$332,506	709	0.0%	Shares	Sole	2023-07-13
2023-03-31	$243,484	709	+3.7%	Shares	Sole	2023-04-18
2022-12-31	$250,234	684	—	Shares	Sole	2023-04-14
No filing history on record for this holder in this stock.